The Effects of CBT and tDCS on Fibromyalgia Patients
Completed · Not applicable · Has a placebo group
Conditions studied: Fibromyalgia, Chronic Pain
In brief
Investigators are seeking to determine the effects of CBT, anodal tDCS over left DLPFC, and combined CBT+ tDCS on clinical pain and functioning among a sample of patients with fibromyalgia. This study will be the first randomized, double-blind, controlled study of tDCS technology as an adjunctive pain management strategy for fibromyalgia pain. Data from this trial will likely yield information regarding the feasibility and efficacy of tDCS+CBT as a chronic pain-management approach.
Key facts
- Study ID
- NCT02723175
- Run by
- Medical University of South Carolina
- People needed
- 15
- Starts
- 2014-12-01
- Expected to finish
- 2017-09-01
- Last updated by the study team
- 2018-11-28
Who can join
Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Meet the American College of Rheumatology criteria for diagnosis of fibromyalgia for at least 1 year.
- Between the ages of 21 and 85
You may not qualify if…
- Other chronic pain conditions
- on chronic opioid therapy
- history of seizures
- are or might be pregnant
- metal/electronic implants or devices above the waist
- moderate to severe depression (HDRS >19)
- moderate to severe anxiety (BAI >16)
- Latex allergy
- Psychiatric illness other than mild depression or anxiety
- on medications that lower seizure threshold
Where it is running
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.